Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
  <li>JVM Co., Ltd. (054950 KS) is a global leader and the dominant domestic manufacturer of pharmacy automation systems, commanding an estimated market share exceeding 80% in South Korea with an accelerating export presence across North America and Europe.</li>
  <li>The company operates an attractive razor-and-blade business model where high-value equipment installations (ATDPS, MENITH, INTIPharm) generate high-margin (50–60% gross margin), highly recurring revenue streams from proprietary consumables (specialized thermal paper and ink ribbons) and maintenance contracts.</li>
  <li>At the current share price of KRW 24,300, JVM trades at an undemanding valuation of approximately 9.0x LTM P/E with a 2.67% dividend yield, zero net debt, and a 3-year EPS CAGR of 21.56%, offering institutional investors an attractive risk-reward profile backed by robust cash flow compounding.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  JVM Co., Ltd. (054950 KS) is a global leader and the dominant domestic manufacturer of pharmacy automation systems, commanding an estimated market share exceeding 80% in South Korea with an accelerating export presence across North America and Europe.
  The company operates an attractive razor-and-blade business model where high-value equipment installations (ATDPS, MENITH, INTIPharm) generate high-margin (50–60% gross margin), highly recurring revenue streams from proprietary consumables (specialized thermal paper and ink ribbons) and maintenance contracts.
  At the current share price of KRW 24,300, JVM trades at an undemanding valuation of approximately 9.0x LTM P/E with a 2.67% dividend yield, zero net debt, and a 3-year EPS CAGR of 21.56%, offering institutional investors an attractive risk-reward profile backed by robust cash flow compounding.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: Jvm Co Ltd (054950 KS) - Oct 2026

South Korea

JVM CO., LTD. develops, manufactures, and maintains pharmaceutical automated system equipment.  The Company's main products include automatic tablet dispensing & packaging system (ATDPS), automatic medicine packing machines, tablet packaging papers, and tablet counting machines.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Primer: Jvm Co Ltd (054950 KS) - Oct 2026

JVM Co., Ltd. (054950 KS) is a global leader and the dominant domestic manufacturer of pharmacy automation systems, commanding an estimated...

αSK Primers